|
WHO Model List of Essential Medicines (2021)
|
20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE INHIBITORS
|
This medicine has the best evidence for effectiveness and safety.
|
|
Peru
|
20.1 Peripherally Acting Cholinesterase Inhibitors and Muscle Relaxants
|
No observations
|
|
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020
|
03 RELAJANTES MUSCULARES
|
No observations
|
|
Costa Rica. Caja Costarricense de Seguro Social. 2019
|
20. Relajantes musculares
|
No observations
|
|
Paraguay. Lista de Medicamentos Esenciales. 2009
|
03. RELAJANTES MUSCULARES
|
No observations
|
|
Chile. Formulario Nacional de Medicamentos. 2005
|
01.04. RELAJANTES MUSCULARES
|
No observations
|
|
Haiti. National List of Essential Medicines
|
20. Muscle Relaxants (Peripheral) and Cholinesterase Inhibitors
|
No observations
|
|
Bahamas. Drug Formulary
|
06.03. Neuromuscular Blockers
|
No observations
|
|
Belize. National Drug Formulary
|
01.04 Muscle relaxants and cholinesterase inhibitors
|
No observations
|
|
Cayman Islands Health Services Authority Pharmacy Drug Formulary
|
15.01.05 Muscle Relaxants
|
No observations
|
